WS #11078

From 500 msgs · 10 key-dev

PetMed Express confirms $3/share acquisition proposal from SilverCape Investments, down from prior $4 offer. European Commission opens antitrust investigation into Align Technology's Invisalign conduct, pressuring ALGN stock. US lawmakers probe Merck and AbbVie over national security risks tied to clinical trials in China.

PetMed Express receives acquisition proposal

PetMed Express confirms $3/share acquisition proposal from SilverCape Investments, down from prior $4 offer.

European Commission opens antitrust investigation into Align Technology's Invisalign conduct, pressuring ALGN stock.

US lawmakers probe Merck and AbbVie over national security risks tied to clinical trials in China.

Full world state #11078 →